Focused radiation before brain surgery, or after it, for cancer that has spread to the brain
Official title: Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study compares giving focused radiation before brain surgery with giving it after.
Read our full plain-language summary
What the trial team says
The purpose of this study is to evaluate the local control rate on the target lesion at 6, 12, and 24 months after treatment with neoadjuvant stereotactic radiotherapy (SRS NEO group) compared to standard care, adjuvant stereotactic radiotherapy (POST OP SRS group).
Key facts
- Registry number
- NCT07437820
- Stage of testing
- Not applicable
- Conditions studied
- Brain Metastases, Adult
Where it is running
This trial lists 1 site.
-
France
- Hôpital Privé Clairval (Marseille)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.